Rise Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-576
Closed -$47.4K – 903
2025
Q3
$47.4K Buy
576
+5
+0.9% +$393 0.02% 263
2025
Q2
$45.9K Buy
571
+9
+2% +$695 0.02% 257
2025
Q1
$45.1K Buy
562
+9
+2% +$748 0.02% 243
2024
Q4
$45.3K Sell
553
-63
-10% -$5.24K 0.02% 253
2024
Q3
$50.8K Buy
616
+63
+11% +$4.71K 0.02% 237
2024
Q2
$38.8K Sell
553
-3
-0.5% -$214 0.02% 289
2024
Q1
$41.2K Buy
556
+297
+115% +$20.7K 0.02% 264
2023
Q4
$17.1K Buy
259
+14
+6% +$876 0.01% 260
2023
Q3
$15.4K Buy
245
+2
+0.8% +$125 0.01% 261
2023
Q2
$13.7K Sell
243
-14
-5% -$777 0.01% 294
2023
Q1
$14.9K Sell
257
-32
-11% -$2.16K 0.01% 298
2022
Q4
$20.9K Sell
289
-23
-7% -$1.65K 0.02% 245
2022
Q3
$19K Buy
312
+2
+0.6% +$128 0.02% 255
2022
Q2
$19K Buy
310
+3
+1% +$199 0.02% 246
2022
Q1
$22K Buy
307
+2
+0.7% +$135 0.02% 234
2021
Q4
$19.1K Buy
+305
New +$19.1K 0.02% 251

Other funds holding MET

Rise Advisors's MET Position: Q4 2025 in Review

Rise Advisors sold out of MetLife (MET) in Q4 2025, closing a stake of 576 shares — an estimated $47.4K sold.

Rise Advisors first reported a position in MET in Q4 2021 and held it in 16 quarters. The position peaked at $50.8K in Q3 2024. 1,447 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • Rise Advisors reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 576 MetLife shares in Q4 2025, an estimated $47.4K.
  • Rise Advisors first reported a position in MetLife in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's MetLife position peaked at $50.8K in Q3 2024.
  • 1,447 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.